Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Nethanel, Asher"'
Autor:
Itamar Averbuch, Ronen Stoff, Mor Miodovnik, Shlomit Fennig, Gil Bar‐Sela, Alexander Yakobson, Jonathan Daliot, Nethanel Asher, Eyal Fenig
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12065-12070 (2023)
Abstract Background Merkel cell carcinoma (MCC) is a rare and aggressive malignancy of the skin, affecting predominantly the fair‐skinned older population exposed to high levels of ultraviolet light. Immune suppression is considered a significant r
Externí odkaz:
https://doaj.org/article/a3ed64bea1fa4230946ceb76d10f6235
Autor:
Iris Barshack, Ronnie Shapira-Frommer, Kenneth Bloom, Nethanel Asher, Guy Ben-Betzalel, Becky Arbiv, Assaf Debby, Ron Elran, Pinchas Birnbaum, Shai Bookstein, Tal Dankovich, Lena Tsabari, Yuval Shachaf, Yoad Cohen, Amit Bart, Oscar Puig, Ettai Markovits
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/f73b7ded66fc4ddda7909f14ed960342
Autor:
Iris Barshack, Ronnie Shapira-Frommer, Kenneth Bloom, Nethanel Asher, Guy Ben-Betzalel, Becky Arbiv, Assaf Debby, Ron Elran, Pinchas Birnbaum, Shai Bookstein, Tal Dankovich, Lena Tsabari, Yuval Shachaf, Yoad Cohen, Amit Bart, Oscar Puig, Ettai Markovits
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/40e74a318ef54b12af57e9a04683fa4b
Autor:
Ronen Stoff, Nethanel Asher, Shachar Laks, Yael Steinberg, Jacob Schachter, Ronnie Shapira-Frommer, Shirly Grynberg, Guy Ben-Betzalel
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionImmunotherapy has revolutionized the prognosis of patients with metastatic melanoma. To date, the most active regimen is the combination of ipilimumab + nivolumab (ipi-nivo) achieving a response rate of nearly 60% and a median survival (O
Externí odkaz:
https://doaj.org/article/0c4a06338f88449a95d93c71cbbcb006
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Clinical trials are an essential source for advances in oncologic care, yet the enrollment rate is only 2-4%. Patients' reluctance to participate is an important barrier. This study evaluates patients' level of understanding and a
Externí odkaz:
https://doaj.org/article/428559502c1f47f49233d33f17a7348c
Autor:
Nethanel, Asher1 (AUTHOR) asher.nati@gmail.com, Kyprianou, Christofis2 (AUTHOR) kyprianouchristofis@gmail.com, Barzilai, Aviv3 (AUTHOR) aviv.barzilai@sheba.health.gov.il, Shapira-Frommer, Ronnie1 (AUTHOR) shirly.grynberg@sheba.health.gov.il, Shoham, Yaron4 (AUTHOR) yshoham@bgu.ac.il, Kornhaber, Rachel2,5 (AUTHOR) rkornhaber@csu.edu.au, Cleary, Michelle6 (AUTHOR) m.cleary@cqu.edu.au, Avinoam-Dar, Galit2,7 (AUTHOR) dr.avinoamdar@gmail.com, Grynberg, Shirly1 (AUTHOR), Haik, Josef2,7,8,9 (AUTHOR) josef.haik@sheba.health.gov.il, Debby, Assaf3 (AUTHOR), Harats, Moti2,7,8,9 (AUTHOR) moti.harats@sheba.health.gov.il
Publikováno v:
Life (2075-1729). Sep2023, Vol. 13 Issue 9, p1803. 11p.
Autor:
Ronen Stoff, Shirly Grynberg, Nethanel Asher, Shachar Laks, Yael Steinberg, Jacob Schachter, Ronnie Shapira-Frommer, Guy Ben-Betzalel
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionImmunotherapy has revolutionized metastatic Melanoma therapy. The most active regimen is combination therapy of Ipilimumab-Nivolumab (Ipi-Nivo) with response rates (RR) of ~60% and median overall survival (OS) of ~6 years. Immune-related
Externí odkaz:
https://doaj.org/article/b7b876f9b0114b0f8b5148fb83ba01c2
Autor:
Shirly Grynberg, Ronen Stoff, Nethanel Asher, Ronnie Shapira-Frommer, Jacob Schachter, Ory Haisraely, Yaacov Lawrence, Guy Ben-Betzalel
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Introduction: Uveal melanoma (UM) is a subtype of melanoma arising from the ocular region. Despite various local therapies available, a significant portion of patients develop distant metastases, primarily to the liver. While cutaneous melanoma is ve
Externí odkaz:
https://doaj.org/article/478e95244ad742008c4e1ee2a6de7381
Autor:
Ronnie Shapira-Frommer, Robert Segal, Gal Markel, Nethanel Asher, Ayala Tamir, Hagit Harati, Ronen Stoff, Shirly Grynberg, Adam Ostrowski, Lawrence Florin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/2ac901a7449f435f9fa9ba8ed5696e81
Autor:
Ettai Markovits, Ortal Harush, Erez N. Baruch, Eldad D. Shulman, Assaf Debby, Orit Itzhaki, Liat Anafi, Artem Danilevsky, Noam Shomron, Guy Ben-Betzalel, Nethanel Asher, Ronnie Shapira-Frommer, Jacob Schachter, Iris Barshack, Tamar Geiger, Ran Elkon, Michal J. Besser, Gal Markel
Publikováno v:
Cancer Immunology Research. :OF1-OF16
Immunotherapy has revolutionized the treatment of advanced melanoma. Because the pathways mediating resistance to immunotherapy are largely unknown, we conducted transcriptome profiling of preimmunotherapy tumor biopsies from patients with melanoma t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07dd5ec9c8096632ab6365a7263028aa
https://doi.org/10.1158/2326-6066.cir-22-0184
https://doi.org/10.1158/2326-6066.cir-22-0184